These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1280718)

  • 1. Effects of yohimbine on heart rate variability in panic disorder patients and normal controls: a study of power spectral analysis of heart rate.
    Yeragani VK; Berger R; Pohl R; Srinivasan K; Balon R; Ramesh C; Weinberg P; Berchou R
    J Cardiovasc Pharmacol; 1992 Oct; 20(4):609-18. PubMed ID: 1280718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of nortriptyline on heart rate variability in panic disorder patients: a preliminary study using power spectral analysis of heart rate.
    Yeragani VK; Srinivasan K; Pohl R; Berger R; Balon R; Ramesh C
    Neuropsychobiology; 1994; 29(1):1-7. PubMed ID: 8127417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased heart rate variability in panic disorder patients: a study of power-spectral analysis of heart rate.
    Yeragani VK; Pohl R; Berger R; Balon R; Ramesh C; Glitz D; Srinivasan K; Weinberg P
    Psychiatry Res; 1993 Jan; 46(1):89-103. PubMed ID: 8464959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heart rate and QT interval variability: abnormal alpha-2 adrenergic function in patients with panic disorder.
    Yeragani VK; Tancer M; Uhde T
    Psychiatry Res; 2003 Dec; 121(2):185-96. PubMed ID: 14656453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behavioral, sympathetic and adrenocortical responses to yohimbine in panic disorder patients and normal controls.
    Gurguis GN; Vitton BJ; Uhde TW
    Psychiatry Res; 1997 Jun; 71(1):27-39. PubMed ID: 9247979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anxiogenic properties of yohimbine. I. Behavioral, physiological and biochemical measures.
    Albus M; Zahn TP; Breier A
    Eur Arch Psychiatry Clin Neurosci; 1992; 241(6):337-44. PubMed ID: 1504110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Avoidant coping in panic disorder: a yohimbine biological challenge study.
    Kaplan JS; Arnkoff DB; Glass CR; Tinsley R; Geraci M; Hernandez E; Luckenbaugh D; Drevets WC; Carlson PJ
    Anxiety Stress Coping; 2012 Jul; 25(4):425-42. PubMed ID: 21864204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of nortriptyline on yohimbine-induced changes in heart rate variability.
    Yeragani VK
    Biol Psychiatry; 1996 Mar; 39(5):385-6. PubMed ID: 8704075
    [No Abstract]   [Full Text] [Related]  

  • 9. Power spectrum of the QRS complex in patients with panic disorder and normal controls.
    Yeragani VK; Berger R; Songer DA; Yeragani S
    Psychiatry Res; 1997 Feb; 66(2-3):167-74. PubMed ID: 9075280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Panic disorder, autonomic nervous system and dissociation - changes during therapy.
    Prasko J; Latalova K; Diveky T; Grambal A; Kamaradova D; Velartova H; Salinger J; Opavsky J; Silhan P
    Neuro Endocrinol Lett; 2011; 32(5):641-51. PubMed ID: 22167145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurobiological mechanisms of panic anxiety: biochemical and behavioral correlates of yohimbine-induced panic attacks.
    Charney DS; Woods SW; Goodman WK; Heninger GR
    Am J Psychiatry; 1987 Aug; 144(8):1030-6. PubMed ID: 3037926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased heart-period variability in patients with panic disorder: a study of Holter ECG records.
    Yeragani VK; Sobolewski E; Igel G; Johnson C; Jampala VC; Kay J; Hillman N; Yeragani S; Vempati S
    Psychiatry Res; 1998 Mar; 78(1-2):89-99. PubMed ID: 9579705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Linear and nonlinear measures of blood pressure variability: increased chaos of blood pressure time series in patients with panic disorder.
    Yeragani VK; Mallavarapu M; Radhakrishna RK; Tancer M; Uhde T
    Depress Anxiety; 2004; 19(2):85-95. PubMed ID: 15022143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. QT interval variability in panic disorder patients after isoproterenol infusions.
    Pohl R; K Yeragani V
    Int J Neuropsychopharmacol; 2001 Mar; 4(1):17-20. PubMed ID: 11343625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anxiogenic properties of yohimbine. II. Influence of experimental set and setting.
    Albus M; Zahn TP; Breier A
    Eur Arch Psychiatry Clin Neurosci; 1992; 241(6):345-51. PubMed ID: 1504111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased chaos of heart rate time series in children of patients with panic disorder.
    Srinivasan K; Ashok MV; Vaz M; Yeragani VK
    Depress Anxiety; 2002; 15(4):159-67. PubMed ID: 12112720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lactate sensitivity and cardiac cholinergic function in panic disorder.
    Yeragani VK; Srinivasan K; Balon R; Ramesh C; Berchou R
    Am J Psychiatry; 1994 Aug; 151(8):1226-8. PubMed ID: 8037261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of yohimbine and hydrocortisone on panic symptoms, autonomic responses, and attention to threat in healthy adults.
    Vasa RA; Pine DS; Masten CL; Vythilingam M; Collin C; Charney DS; Neumeister A; Mogg K; Bradley BP; Bruck M; Monk CS
    Psychopharmacology (Berl); 2009 Jun; 204(3):445-55. PubMed ID: 19266185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noradrenergic function in panic anxiety. Effects of yohimbine in healthy subjects and patients with agoraphobia and panic disorder.
    Charney DS; Heninger GR; Breier A
    Arch Gen Psychiatry; 1984 Aug; 41(8):751-63. PubMed ID: 6742977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exaggerated beat-to-beat R amplitude variability in patients with panic disorder after intravenous isoproterenol.
    Yeragani VK; Pohl R; Bär KJ; Chokka P; Tancer M
    Neuropsychobiology; 2007; 55(3-4):213-8. PubMed ID: 17873495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.